Latest / Stock Movers / Eli Lilly Gains on Experimental Shot, Gemini Space Station Rises, Oracle Sinks on 3Q Forecast
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, Podcasts, Radio News.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 1: I'm Jim Steneveec along with Carol Master. Let's take a
- 0:18Speaker 1: look at some stocks on the move today with us
- 0:20Speaker 1: as Bloomberg News Cross Asset reporter Isabel Lee. Isabelle. A
- 0:24Speaker 1: lot of stocks moving today. One to the upside, Eli Lilly.
- 0:27Speaker 3: We have to talk about Eli Lilly. So the stock
- 0:30Speaker 3: was hired by around three percent. Now it's paired by
- 0:32Speaker 3: some of those games, but still up by one and
- 0:34Speaker 3: a half percent. So investors are cheering a next generation
- 0:37Speaker 3: obesity shot that helps patients lose as much as twenty
- 0:41Speaker 3: three percent of their body weights a lot. I know,
- 0:42Speaker 3: I was computing in my head and I was like,
- 0:44Speaker 3: that is a lot.
- 0:45Speaker 4: It's a lot.
- 0:46Speaker 3: No matter how much you weigh, that is a lot. Yeah,
- 0:48Speaker 3: And this could potentially make the experimental drug the most
- 0:51Speaker 3: potent weight loss medicine yet. So patients on the highest
- 0:54Speaker 3: dose of the drug lost nearly a quarter over the
- 0:56Speaker 3: weight in sixty eight weeks, so that's more than a year.
- 1:00Speaker 3: And the study participants experience a sixty two percent reduction
- 1:03Speaker 3: in knee pain. And I was talking to an author
- 1:05Speaker 3: of the story at Madison Muller and I was telling
- 1:07Speaker 3: her that, you know, when you think about weight loss,
- 1:09Speaker 3: people usually associated with superficiality or looks, but it actually
- 1:14Speaker 3: really helps people who have medical problems, and it can
- 1:17Speaker 3: help you with your lifestyle improvement and just overall make
- 1:20Speaker 3: you healthier. And why is this a big deal Because
- 1:23Speaker 3: the obesity market is expected to hit around one hundred
- 1:25Speaker 3: billion dollars by twenty thirty, which is massive.
- 1:28Speaker 4: I mean, listen, we have just talked about how overweight
- 1:32Speaker 4: the American population is and diabetes. How many Americans are
- 1:35Speaker 4: either pre diabetic or diabetic. It's a large proportion, I
- 1:39Speaker 4: want to say, like forty or fifty percent of our
- 1:41Speaker 4: population easily. And so if you think about what this
- 1:45Speaker 4: can do in terms of for some people who are
- 1:48Speaker 4: having a hard time losing weight who are diabetic, this
- 1:51Speaker 4: can be a game changer. And we kid with madisone
- 1:53Speaker 4: all the time, like is this the drug that's going
- 1:55Speaker 4: to fix all that ailss? But it kind of gets
- 1:57Speaker 4: down to that point that it being overweight is I
- 2:00Speaker 4: know it's hard for some people in terms of weight management.
- 2:02Speaker 4: But it is a much healthier thing to be is
- 2:07Speaker 4: not be overweight.
- 2:08Speaker 3: Yes, the ticker is Lly and the company's shot that
- 2:10Speaker 3: zep bound is alth I did a most popular But
- 2:12Speaker 3: of course Lily is trying to develop and raising develop
- 2:15Speaker 3: drugs that are more effective, and the competition there is
- 2:17Speaker 3: also intense.
- 2:19Speaker 1: I was looking at Yeah, what are you looking at?
- 2:21Speaker 4: Over thirty eight million Americans have diabetes roughly one intent.
- 2:25Speaker 4: So it's not maybe.
- 2:26Speaker 3: Look up good job. That's a lot of.
- 2:28Speaker 4: Silly little thing called Google.
- 2:29Speaker 3: Yeah, not chat, GPTWO.
- 2:32Speaker 1: No, I didn't get there. I didn't get there.
- 2:35Speaker 4: But it says over one point three billion. This is
- 2:37Speaker 4: a Bloomberg story. Actually this is a couple of years ago.
- 2:39Speaker 4: Over one point three billion globally will have diabetes by
- 2:42Speaker 4: twenty to fifty. So that's a lot of folks. All right,
- 2:45Speaker 4: So Eli, Lilly a gainer.
- 2:46Speaker 1: What about Gemini space station the fintech firm.
- 2:49Speaker 3: This is a big gainer up by twenty five percent.
- 2:53Speaker 3: So Gemini, when you think about it, where you're a
- 2:55Speaker 3: crypto show, why oh nothing.
- 2:59Speaker 4: Because I have to do gainers. But I should have
- 3:00Speaker 4: done this one anyway, Go.
- 3:01Speaker 3: Ahead and Carol, it's twenty five percent.
- 3:04Speaker 1: You get to say Gemini space station exactly.
- 3:07Speaker 3: So, Tim, who is the crypto show, you would know
- 3:09Speaker 3: that when you hear Gemini, you think it's like a
- 3:11Speaker 3: crypto exchange. But then no, of course they're trying to
- 3:13Speaker 3: also muscle their way into the fast moving field of
- 3:16Speaker 3: prediction markets.
- 3:17Speaker 1: I knew you were going to say that they can't.
- 3:18Speaker 3: They their application for a derivative exchange was approved better
- 3:22Speaker 3: c of TC, so now they're clearly expanding and according
- 3:25Speaker 3: to their website, it will allow soon existing u AS
- 3:28Speaker 3: customers to trade events contract And this is interesting because
- 3:31Speaker 3: increasingly cryptonated firms like poly market have been straddling digital
- 3:36Speaker 3: assets prediction markets. Now a lot are trying to do both,
- 3:40Speaker 3: and many firms have really expressed interest in this.
- 3:43Speaker 1: I want to know when they're going to build the
- 3:44Speaker 1: space station.
- 3:46Speaker 4: Yspace station ticker g E M I why are they
- 3:49Speaker 4: Semini space station?
- 3:50Speaker 1: I still think of it as being called Gemini, but
- 3:51Speaker 1: the official name is Gemini Space winkle loss.
- 3:58Speaker 3: Yeah, right, some people should winkle y because it's the
- 4:00Speaker 3: plural of winkle monkele pize.
- 4:02Speaker 4: Can I just say forty two percent of the float
- 4:04Speaker 4: is short on this puppy. Oh, so that's a little
- 4:08Speaker 4: bit of negative since just gonna put that out there,
- 4:11Speaker 4: even though it's flying high today, Oracle not flying high today.
- 4:15Speaker 3: Not flying high. Down by ten percent, that's I think
- 4:17Speaker 3: the most since at least January, erasing more than one
- 4:20Speaker 3: hundred billion dollars in market value, and at one point
- 4:23Speaker 3: was on track to close with its steepest one day
- 4:26Speaker 3: drop since two thousand and one.
- 4:27Speaker 4: It's a long time twenty four years ago.
- 4:30Speaker 3: So again this comes after, of course, the company said
- 4:32Speaker 3: that its capital expenditure is about to reach fifty billion
- 4:34Speaker 3: dollars by the end of the fiscal year ending in
- 4:36Speaker 3: May twenty twenty six. Annual revenue will be around sixty
- 4:39Speaker 3: seven billion dollars. So this is interesting because again it's
- 4:42Speaker 3: like AI hopes and dreams. I've talked to some analysts
- 4:45Speaker 3: and they were like, Oracle gave investors everything they want
- 4:48Speaker 3: on paper, but of course you still hope for more
- 4:50Speaker 3: and more. And cloud sales increased Acid revenue, but both
- 4:54Speaker 3: fell short of estimates, and the latest support just really
- 4:57Speaker 3: makes you think of the reversal fortunes of Oracle, which
- 5:00Speaker 3: earlier this year was just having a blistering rally. Remember
- 5:03Speaker 3: its co founder Larry Ellison was at one point the
- 5:05Speaker 3: richest men Honors, richer than Elon Musk. Yeah, but now
- 5:09Speaker 3: we're seeing shares down by ten percent. Ticker is ourcl.
- 5:14Speaker 2: The stock moover's report from Bloomberg Radio. Check back with
- 5:19Speaker 2: us throughout the day for the latest roundup of companies
- 5:21Speaker 2: making news on Wall Street and for the latest market
- 5:24Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 5:29Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 5:32Speaker 2: the Bloomberg Business app.